ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. [electronic resource]
- Cancer biology & therapy Sep 2010
- 600-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't